about
Therapeutic modulation of the natural history of coronary atherosclerosis: lessons learned from serial imaging studiesNeointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcinePercutaneous coronary intervention versus coronary artery bypass grafting in patients with coronary artery disease and diabetic nephropathy: a single center experienceEndoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transitionImpact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty RevascuVinpocetine attenuates neointimal hyperplasia in diabetic rat carotid arteries after balloon injury.Inadequate blood glucose control is associated with in-hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery.Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function.Ischemia-reperfusion injury leads to distinct temporal cardiac remodeling in normal versus diabetic miceSecond- versus first-generation drug-eluting stents for diabetic patients: a meta-analysis.Coronary revascularization in diabetic patients: Current state of evidence.Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting.Glycated hemoglobin HbA1c - a new risk marker for the outcome of cardiac surgery?Oxidized LDL and Fructosamine Associated with Severity of Coronary Artery Atherosclerosis in Insulin Resistant Pigs Fed a High Fat/High NaCl Diet.Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapyPercutaneous coronary interventions with drug eluting stents for diabetic patientsHeart Surgery Waiting Time: Assessing the Effectiveness of an Action.Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting.Management of patients with type 2 diabetes after acute coronary syndromes.Cutaneous lymphomas--radiotherapeutic strategies.Swine models of type 2 diabetes mellitus: insulin resistance, glucose tolerance, and cardiovascular complications.The role of adherence in the relationship between self-efficacy and self-management in diabetic patients undergoing CABG in TaiwanMyocardial revascularization: surgery or stenting?Value of exercise tolerance testing in evaluation of diabetic patients presented with atypical chest discomfort.Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularizationPreexisting high expression of matrix metalloproteinase-2 in tunica media of saphenous vein conduits is associated with unfavorable long-term outcomes after coronary artery bypass grafting.The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus.Identification of a coronary vascular progenitor cell in the human heartChange in enrollment patterns, patient selection, and clinical outcomes with the availability of drug-eluting stents in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.National trends in utilization and outcomes of coronary revascularization procedures among people with and without type 2 diabetes in Spain (2001-2011).National trends over one decade in hospitalization for acute myocardial infarction among Spanish adults with type 2 diabetes: cumulative incidence, outcomes and use of percutaneous coronary intervention.Comparison of endothelial function of coronary artery bypass grafts in diabetic and nondiabetic patients: Which graft offers the best?Interventional Revascularization of Coronary Artery Lesions in Diabetic Patients; In-hospital and One Year Follow upAngiographic and Clinical Impact of Successful Manual Thrombus Aspiration in Diabetic Patients Undergoing Primary PCI.Meta-analysis of percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with diabetes and left main and/or multivessel coronary artery disease.Oxidative stress and myocardial injury in the diabetic heartPerioperative control of blood glucose level in cardiac surgery.The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials.
P2860
Q26738588-BA4EFF41-D29E-42A2-A1BF-9157D8437651Q28212482-19BC5267-BF85-4849-AAA5-132D79070E99Q28222796-BCF35A89-8A43-4FC6-A7BF-594AAB09DD5DQ28577217-4314F3F4-D21C-4D3C-AA79-017D6DA365DAQ30411237-BC24DF0E-5BD1-4A45-B6ED-DE0801860BDAQ33599923-644230A3-D814-4A78-BDA7-B7126183E8F7Q33761860-2E9F240E-A772-4F0C-BE65-3A05ED280B03Q34001116-4D9645D9-0906-4BB9-A4DF-D2DCD7993B7FQ34162518-BB5B5055-1BA6-48C8-A500-0F9CC37EADA0Q34662245-D4922F22-A6A4-44E9-A1D1-33DF7E4BDCA1Q34789840-597E471A-D223-4585-9821-9332F7164957Q34793647-7B0C1FEA-C796-4EA7-AE0D-61BA7DEA76B9Q34821881-E0D771E4-0035-4166-AF1F-1B0C10F1157BQ35684097-35D90549-FA94-40C3-BD8F-6E139A0A40DDQ35691400-4F4DA9EC-3255-44A0-8D21-FCCDA0B4E35EQ35755253-70825CA9-D9B8-4A9F-AFC2-4D260B8DC8FDQ35771445-0953E137-74BE-4E44-A989-06E52349B164Q36098463-D69B5E4C-377D-4BAE-AD7A-89DB229458B4Q36241566-4D6391D5-7CF3-45EE-9848-5BE46DAF14E3Q36333931-AB466C2F-32B1-4AF4-8DE5-FFBF4E880F92Q36361226-BD735EDC-71A4-4295-BC3A-AA9CAD82877AQ36521113-DAF510D6-6563-4BA2-9649-E614B5AD834DQ36800773-77FD2C06-393B-4635-9DDD-0A14142741B8Q36836467-100CAA23-3CFB-4A5A-90A1-B50ACE940635Q36957436-0278F956-2B8E-460C-AF30-E620BBB52C1FQ37167506-918C5184-3021-4A6E-82FA-67E379EBF024Q37208634-A0ABC93B-E637-40D1-B1D2-EEA3C7BF790CQ37306857-A9A823C4-0270-4EE3-A6FC-3BE07855FE56Q37354199-E303A6B4-19D5-47F5-86CB-3E19F8AC68EBQ37403027-79E14FD6-F724-42EA-B8A8-80EE0C2891CFQ37436407-1A78E38F-B1B1-48EA-BF7F-29AA1604B26BQ37484180-E54EF7EF-7E7F-4114-9CC5-ACB636912500Q37680446-89B55C4B-4373-4AEF-B1E1-BA2630958995Q37703974-A0D54799-B4AA-4ABE-B47E-F7B247E85DB2Q37718905-E21509B1-0128-46F0-A368-4E678F0C66B9Q38036173-6E34BB8C-03DB-4A39-9752-39AB9265E9FEQ38046547-C3676E65-EA6F-4FF1-8870-38859B7333DCQ38071968-98A0BA52-6659-4836-8ADF-9A01CA529F0DQ38103313-D8906C5A-0544-4CB8-BABB-7950754DB096Q38381704-C325C4FC-6FB3-4433-9D34-E4242192AFAB
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Diabetes and coronary revascularization.
@ast
Diabetes and coronary revascularization.
@en
type
label
Diabetes and coronary revascularization.
@ast
Diabetes and coronary revascularization.
@en
prefLabel
Diabetes and coronary revascularization.
@ast
Diabetes and coronary revascularization.
@en
P356
P1476
Diabetes and coronary revascularization.
@en
P2093
Charles J Davidson
James D Flaherty
P304
P356
10.1001/JAMA.293.12.1501
P407
P577
2005-03-01T00:00:00Z